Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.

about

Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations.

P2860

Q41695361-91F90C52-5E1F-482C-B9B3-CED97EBBA090

P2860

Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.

Item

http://www.wikidata.org/entity/Q36887732

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ampicillin in Combination with ...... ccus faecalis Infection Model.

@en

type

Item

label

Ampicillin in Combination with ...... ccus faecalis Infection Model.

@en

prefLabel

Ampicillin in Combination with ...... ccus faecalis Infection Model.

@en

P1476

Ampicillin in Combination with ...... ccus faecalis Infection Model.

@en

P2093

Kerry L LaPlante

http://www.w3.org/2001/XMLSchema#string

Louis B Rice

http://www.w3.org/2001/XMLSchema#string

Megan K Luther

http://www.w3.org/2001/XMLSchema#string

P2860

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage

Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients.

Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.

Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.

Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora.

Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.

Pharmacokinetics of ceftriaxone in humans.

P304

3178-3182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03126-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26926624

http://www.w3.org/2001/XMLSchema#string

P932

4862448

http://www.w3.org/2001/XMLSchema#string

Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.

about

P2860

P2860

Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932